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Summary. This retrospective study was conducted in 521 
men with micturition complaints to determine the relation­
ship between prostate size and bladder-outlet obstruction. 
Analysis showed a statistically significant correlation be­
tween bladder-outlet obstruction and prostate size. Urody- 
namic bladder-outlet obstruction was confirmed in 90%  of 
the patients with a prostate size of more than 80 cm3. In 
32% of the patients with a prostate smaller than 40 cm3, no 
urodynamic evidence of bladder-outlet obstruction was 
found. There was no correlation between symptom scores 
(Madsen and I-PSS) and the grade of bladder-outlet ob­
struction or prostate size. We conclude that precise deter­
mination of the prostate size and urodynamics investiga­
tions are important (complementary) parameters in the as­
sessment of elderly men with micturition complaints.
The prostate size can be an important parameter in the in­
vestigation of patients with micturition complaints and is 
frequently used to decide between possible treatment 
modalities: transurethral prostatectomy (TURP) or supra­
pubic prostatectomy [1]. For many years, the gold stan­
dard for the evaluation of the size of the prostate was the 
urologist’s fingertip. Unfortunately, the accuracy of this 
investigation appears to be low [2]. Nowadays the techni­
cal possibilities enable us to measure the in vivo volume 
of the prostate with transrectal ultrasound (TRUS) inves­
tigation, with computerized tomography (CT)-scan imag­
ing, or with magnetic resonance imaging (MRI). Tran- 
srectal volumetry has shown a good correlation with the 
actual prostate size [3-5]. The most accurate and reliable 
method to determine the volume of the prostate appears to 
be the planimetrie method [6 , 7].
The correlation of prostate size with clinical parame­
ters such as age, duration of symptoms, pattern of symp­
toms, and uroflow parameters is reported to be low 
[8-10]. There seems to be agreement in the observation
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that patients with larger prostates fare better after prostate 
resection [1, 11-13]. On the other hand, patients with 
small prostates do not need an extensive resection of pro­
static tissue [14, 15]. In the majority of clinical (outcome) 
studies, the prostate size is estimated by rectal examina­
tion or by resected tissue weight.
The principle idea of removal of prostate tissue is to 
relieve outlet obstruction. However, not all men with mic­
turition complaints treated by TURP have bladder-outlet 
obstruction (BOO). The introduction of advanced urody­
namics investigation, which is considered to be the “gold 
standard” for the measurement of outlet obstruction, has 
shed a new light on this topic. Several authors came to the 
conclusion that up to one-third of the patients treated for 
benign prostatic hyperplasia (BPH) had no proven BOO 
[16-18]. On the other hand, several other investigators 
found that the estimated prostate size was associated in­
versely with urethral obstruction [19-21],
In view of the data available at the moment, an in­
creasing number of urologists are questioning the rela­
tionship between prostate size and outlet obstruction. In 
this article we attempt to clarify this issue and present the 
results of a retrospective study conducted to investigate 
the correlation of prostate size with urodynamic parameters.
Patients and methods
The results of urodynamics investigations of 521 men with lower- 
urinary-tract symptoms were evaluated. These results were corre­
lated with the results of prostate size, measured by TRUS, and 
with the results of the (I-PSS and Madsen) symptom scores. Uro­
dynamics investigations were performed with an 8-F transurethral 
lumen catheter equipped with an intravesical microtip pressure 
sensor for bladder pressure recording. Abdominal pressure was 
recorded intrarectally with an 8-F micro tip sensor catheter (MTC, 
Dräger, Germany). Before cystometry the bladder was emptied 
through the lumen of the transurethral catheter. The bladder was 
filled with water of 20° C with a filling speed of 50 ml/min. Com­
mercially available equipment (UD 2000; MMS, Enschede, the 
Netherlands) was used to record the pressure and flow data. Digi­
tally stored data were translated to a urodynamics-analysis com­
puter program developed at our department (UIC/BME Research 
Center, Department of Urology, Nijmegen, the Netherlands).
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To provide an objective and precise grade of obstruction, P/Q 
graphs were fitted with a passive urethral resistance relation 
(PURR) curve at the lowest pressure part of the graph. The mini­
mal urethral opening pressure (Pmu0) and theoretical urethral lumen 
(Atheo) were calculated automatically on the basis of the manually 
adjusted PURR curves [22], The urethral resistance factor (URA) 
was computed to enable the classification of patients on a continu­
ous, one-parameter scale of obstruction [23]. Calculation of the 
URA was based on the positioning of a haircross on the point of 
maximal flow and corresponding detrusor pressure (Pdet at Qmax). 
Correction for (maximal) flow artifacts was performed when nec­
essary. We also added a nonparametric analysis of obstruction and 
prostate size with clinical classes according to the linearized 
PURR (L-PURR) P/Q nomogram [24], For evaluation of the void­
ing efficiency, the voided percentage, which is the relative amount 
of bladder content that was expelled, was calculated.
The TRUS examinations were performed using a Kretz combi- 
son 330 ultrasound scanner with a 7.5-MHz transrectal transducer 
(Multiplane 3-D VRW 77AK). The prostate was imaged in the 
transverse plane starting at the base, and cross-section images were 
stored every 4 mm by retracting the probe with a fixture until the 
apex of the prostate was reached. After outlining of the prostate at 
every cross section with a pencil-follower, the volume is calculated.
For statistical analysis, we used Spearman correlation coeffi­
cients in the analysis of correlation, chi-square tests to compare 
proportional groups, and Student’s /-test to test the mean differ­
ences between groups.
N
Results
The mean prostate size in this group of patients was 44.1 
cm3 (range, 12-170 cm3). Figure 1 shows a histogram of 
the prostate sizes. The mean age of the patients was 64.5 
(range, 42.7-90.7) years. The mean maximal uroflow was
7.6 ml/s (SD, 4.1 ml/s; range, 1.0-42.0 ml/s). According 
to the L-PURR nomogram, 140 patients (26.9%) were 
considered unobstructed (L-PURR grades 0 and 1), 317 
patients (60.8%) had a moderate grade of outlet obstruc­
tion (L-PURR grades 2-4), and 63 (12.1%) had a severe 
outlet obstruction (grades 5 and 6). Figure 2 shows the bar 
chart of 20 -cm3 pros täte-volume groups subdivided into 
relative numbers of patients in the various L-PURR 
classes.
Table 1 shows the mean cystometry parameters. The 
mean URA value was 37.6 cmH20 . As value of more than 
28 cmH20  is considered to be indicative for BOO, the 
mean outlet obstruction in these patients was '‘moderate” 
[25]. The Pmuo value of 32.0 cmH20  and the Atheo value of
3.6 mm2 indicate a moderate, average degree of outlet ob­
struction for the entire group as well. Table 2 shows the 
mean age and prostate size, the voided percentages, the 
total symptom scores of the patients, and the various L- 
PURR classes of BOO. One can recognize a trend toward 
an increase in age and prostate volume with increasing 
obstruction class. There appears to be no correlation be­
tween the results of the I-PSS or Madsen symptom scores 
and the classes of BOO. In Table 3 the age and symptom 
scores in 10-cm3 classes of prostate size are listed and 
confirm the aforementioned conclusions. Table 4 shows 
the results of the pressure-flow analysis for each prostate- 
size class. With increasing prostate size, a decrease in 
maximal uroflow, Atheo, and voiding percentage is appar­
ent. The outlet parameters URA and Pmuo increase with 
prostate size.
150 r
120  -
90 -
60 -
30 -
0
< 2 0  2 0 - 3 0  3 0 -4 0  4 0 -5 0  5 0 -6 0  6 0 -7 0  7 0 -8 0  8 0 -9 0  9 0 -1 0 0  >100
Prostate size (cm3)
Fig .l .  Histogram of prostatic volumes (/? = 521)
100%
80%
6 0 %
4 0 %
20%
0%
18
'X s \
272
% 4 » m
IÜ IÉ
PEIÉlii^  O . l  I  * . *  O . l  A  f  « '«m M  iitsv , s v f . v . v . y ( c \ v
O  * « 4 i  \  « «.<P&mm
jv< '  '  ; , v . v  ' v 
•Î X v ljX *" 1 V -v *1 ^
V'V.v<V< w  ><>>>
17 14
mM
V - ? « ‘ •
<20 2 0 -4 0 4 0 -6 0 6 0 -8 0 8 0 -1 0 0 >100
Prostate size (cm3)
Fig.2* Histogram of prostate, size classes (20 cm3), and the per­
centage of patients in the L-PURR classes, U  0-1; SI 2-4; D  5-6
Table 1. Urodynamic parameters of cystometry and pressure/flow 
analysis (n = 521)
Mean SD Range
Bladder capacity (ml) 416 138 100 -951
Residual urine (ml) 65.6 93.0 0 -880
Voided percentage (%) 82 18 9 -100
Maximal flow (ml/s) 7.5 4.1 1 -  42
Mean flow (ml/s) 3.3 1.7 1 -  10.1
Pdet at Qmax (cm H20) 60.6 29.1 4 -166
URA (cm H20 ) 37.6 19.1 2 -107
Pmuo (cm H,0) 32.0 19.0 1 -114
Alhe0 (mm2) 3.6 2.5 0.4- 21.5
The correlations of prostate size with age (0.33), 
voided percentage (-0.19), Qmax (-0.20), Pdet at Qmax 
(0.29), Pmuo (0.32), A the0 (-0.19), and URA (0.32) were 
statistically significant at the P  < 0.001 level. The corre­
lation of prostate size with the I-PSS and Madsen symp­
tom scores and with residual urine was not statistically 
significant. Neither the total Madsen score nor the total
nTable 2. Age, prostate volume, symptoms, 
and voided percentage in relation to 
L-PURR classes of obstruction
n Age
(years)
All 521 64.5
Obstruction class:
0 41 63.2
1 99 63.6
2 123 63.2
3 83 65.0
4 111 65.4
5 45 66.9
6 18 65.8
Prostate Voided Total Total 
volume percentage Madsen Ï-PSS 
(cm3) (%)
44.0 82.0 12.3 17.4
34.2 87.0 12.1 17.1
38.2 86.4 11.7 16,5
38.6 86.9 12.1 17.2
43.6 81.5 11.9 17.0
52.4 78.2 12.4 18.4
57.3 73.9 12.8 16.9
53.4 61.3 15.7 22,3
Table 3. Age and mean symptom score in relation to prostate size
Prostate size 
(cm3) n
Age
(years)
Total
Madsen
Total
1-PSS
All 521 64.5 12.3 17.4
<20 16 61.9 11.2 17.9
20- 30 130 61.2 11.7 16.6
30- 40 142 63.3 12.7 18.4
40- 50 87 65.4 12.8 17.8
50- 60 51 66.6 12.2 17.3
60- 70 40 68.0 12.0 17.0
70- 80 24 69.0 13.6 17.4
80- 90 8 71.6 10.4 15.3
90-100 9 68.9 13.0 15.8
> 100 14 71.5 13.3 16.0
I-PSS score correlated with any parameter of pressure- 
flow analysis.
For further analysis the whole group of patients was 
divided into two groups: those with big prostates (> 40 
cm3, n = 232) and those with small prostates (< 40 cm3, n 
= 288). This borderline was chosen because these groups 
showed a good (significant according to chi-square analy­
sis) correlation with the obstructed L-PURR groups. Of 
the patients with a prostate size of > 40 cm3, 79.7% had 
obstruction according to the L-PURR classification. Ac­
cording to the URA borderline value of 28 cmH20 , 68.7% 
of the patients had BOO when the prostate size exceeded
40 cm3. On the other hand, 47.9% of the patients were not 
obstructed according to URA when the prostate size was 
below 30 cm3. When the group with a prostate size o f > 
40 cm3 was compared with the group with small prostates, 
statistically significant differences in all parameters of 
pressure-flow analysis were observed. The mean Qmax 
recorded in the “big-prostate” group was 6.9 ml/s, where­
as the ‘"small prostates” had a Qmax of 8.1 nil/s. The 
mean URA value was 42.6 cmH20  in the big prostates 
and 33.6 cmH20  in the small prostates.
Discussion
It is generally believed that enlargement of the prostate re­
sults in BOO, which causes the clinical manifestations of 
BPH. The term BPH describes histopathologic abnormal­
ities of the prostate gland. The prevalence of BPH is very 
high in men aged over 50 years, and it rises with each age 
group, attaining a peak of 88% in men aged over 80 years 
[26]. However, the term BPH is usually applied to de­
scribe a condition that can be characterized by nonhisto- 
logic criteria: the presence of symptoms of “prostatism,” 
an enlarged prostate and outlet obstruction [27] -
The majority of elderly men will eventually experi­
ence some voiding symptoms and will seek therapy. For 
decades, TURP has been the first-choice treatment, and it 
aims at reducing infravesical obstruction. Although an en­
largement of the prostate, residual urine, and a decreased 
urine flow may be present, a significant proportion of these
Table 4« Cystometry parameters 
ent prostate-size groups
of differ- prostate size n
(cm3)
<20 16
20- 30 130
30- 40 142
40- 50 87
50- 60 51
60- 70 40
70- 80 24
80- 90 8
90- 100 9
>100 14
Qmax
(ml/s)
PdetQmax 
(cm H20)
URA
(cm H
7.8 51.6 33.8
8.4 53.9 33.1
7.9 55.9 34.0
7.7 58.9 36.5
6.9 61.4 38.2
6.7 74.5 46.0
5.9 82.2 53.3
5.4 96.7 58.0
6.4 75.4 51.3
5.4 82.5 54.5
Primo Atlieo Voided 
20) (cm H20 )  (mm2) (%)
29.3 3.62 73.6
27.3 4.02 87.1
29.0 3.92 84.9
30.3 3.88 79.0
33.7 3.16 80.3
38.0 2.73 77.5
45.1 2.35 77.4
64.2 2.35 73.3
38.2 2.67 66.4
53.5 2.57 76.0
12
patients appear not to be obstructed when urodynamics in­
vestigation is performed [ 16—181, The concept of dividing 
BPH into obstructive and nonobstructive disease may 
have far-reaching consequences for the handling ol indi­
vidual patients. This is one of the reasons why TURP is 
now being questioned as the “gold standard” of treatment 
for every patient with BPH. Moreover, a host of alterna­
tive treatments have emerged in the last few years [28-35].
In the present study we observed a distinct correlation 
of ultrasound-determined prostate size with age and BOO. 
BOO was graded with pressure-flow analysis, considered 
the gold standard for examination of the condition of 
bladder and outlet function. Although never analyzed in 
this way, the results did not come as a surprise. Patients 
with larger prostates have a higher chance of being ob­
structed. Consequently, these patients may improve sig­
nificantly following deobstructive therapy, and this study 
can thus be considered as a confirmation of the clinical 
experience of urologists that deobstruction is more suc­
cessful in patients with larger prostates [11-13]. Patients 
with a smaller prostate have a lesser chance of being ob­
structed and must therefore be treated less invasively.
In all prostate-size groups there was a considerable pro­
portion of urodynamically unobstructed patients: 26.9% of 
all patients analyzed, 32% of the patients with a prostate 
size of < 40 cm3, 30% of those whose prostate measured 
between 40 and 60 cm3, and 10% of those whose prostate 
size was > 60 cm3. The high proportion of unobstructed 
patients is also reported by several other authors [16-18].
From this study we have learned that there is a statisti­
cally significant correlation of prostate size with outlet- 
obstmction parameters but that this correlation is poor. 
Prior to treatment, besides the prostate size, one should be 
informed about the presence and grade of BOO. More­
over, it should be stressed that commonly used prostate- 
symptom scores (I-PSS, Madsen) do not correlate with 
obstruction or with prostate size.
In view of the results of this study, it is indeed impor­
tant that one be aware of the prostate size. The correlation 
of prostate size with BOO is superior to the correlation of 
symptoms with BOO. For evaluation of the function of 
the lower urinary tract, the urodynamics evaluation re­
mains mandatory, especially in patients with relatively 
small prostates.
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